Skip to content

Fostering Resilience to Psychosocial and HIV Risk in Indian MSM

Fostering Resilience to Psychosocial and HIV Risk in Indian MSM

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02556294
Enrollment
608
Registered
2015-09-22
Start date
2015-06-30
Completion date
2019-08-31
Last updated
2019-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behavior, HIV Infection, Sexual Behavior

Keywords

HIV risk behavior

Brief summary

India has the world's third largest HIV epidemic and men who have sex with men (MSM) are an identified high risk group. MSM in India face unique psychosocial stress underlying the context of HIV risk. To maximize the potential impact of an HIV prevention intervention, the purpose of this study is to test, in a two-arm randomized controlled efficacy trial, a behavioral intervention that addresses both psychosocial / contextual stress and reducing participant's risk for HIV.

Detailed description

India has the world's third largest HIV epidemic, and MSM in India have an estimated seroprevalence of 14.7%. Many HIV prevention efforts for MSM in India are limited to condom distribution and HIV education, with no existing efficacy trials of HIV prevention interventions and therefore no evidenced based HIV prevention interventions this population. MSM in India are hidden, stigmatized, and face considerable psychosocial stressors, including pressure to marry, which potentially increases the risk for HIV transmission to their wives. This proposal is the culmination of our ongoing, successful \> 10-year community based research collaboration with two NGOs dedicated to HIV prevention among MSM, Sahodaran (Chennai) and The Humsafar Trust (Mumbai), and investigators from the India Council of Medical Research (ICMR), National Institute for Research in Tuberculosis (NIRT) in Chennai. Our work, including extensive community advisory input, has identified self-acceptance as a key resilience variable that protects against both HIV risk and psychosocial distress. A field test and pilot randomized controlled trial of our behavioral intervention that addresses both HIV risk and self-acceptance showed high participant acceptability and feasibility of study procedures, and success reducing HIV sexual risk behavior. The current study is a two-arm randomized controlled trial to reduce HIV, STI and sexual transmission risk compared to HIV/STI counseling and testing alone.

Interventions

BEHAVIORALSelf-acceptance based intervention

The intervention will consist of HIV/STI counseling and testing as well as individual counseling sessions and group sessions. The primary focus of the group sessions are to help foster self-acceptance by the support from the group, as well as learn skills to reduce distress and HIV risk. The primary purpose of the individual sessions is to help develop and implement an individualized plan for HIV risk reduction, and, as needed and available, linkage to other services.

BEHAVIORALHIV/STI counseling and testing

The counseling component is standard of care in India and will focus on HIV/STI risk and how to minimize risk. This is followed by biological testing for HIV and STIs.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
The National Institute for Research in Tuberculosis
CollaboratorUNKNOWN
Indian Council of Medical Research
CollaboratorOTHER_GOV
Sahodaran
CollaboratorUNKNOWN
The Humsafar Trust
CollaboratorUNKNOWN
Fenway Community Health
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

- One of the following must be true: * Participant has had anal sex with 4 or more male partners (protected or unprotected) in the past 4 months. * Participant has had condomless anal sex with a man who was HIV unknown or serodiscordant in the past 4 months. * Participant has a history of transactional sex activity in the past 4 months. * Participant has been given a diagnosis of an STI in the past 4 months.

Exclusion criteria

* Participant does not identify as male * Younger than 18 * Is unable to understand or consent to the procedures * Is deemed by the local PI or study staff to be engaging in deception about the inclusion/

Design outcomes

Primary

MeasureTime frameDescription
Changes in frequency of condomless sex4 month visit, 8 month visit, 12, month visitSelf-reported insertive or receptive anal sex without the use of a condom.
Number of incident STIs from Baseline12 month visitChlamydia, gonorrhea, syphilis, and HIV

Secondary

MeasureTime frameDescription
Changes in Psychosocial MediatorsMeasured at baseline, 4, 8, 12 month visitsItems will be used to measure potential psychosocial mediators (e.g. self-acceptance questionnaire, distress questionnaire) at each major visit.
Cost-effectiveness of intervention12 monthsTo assess the incremental cost-effectiveness of the experimental versus the comparison condition.

Countries

India, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026